Sign up


Match Document Document Title
8889823 Method to make poly(L-lactide) stent with tunable degradation rate  
Methods of making a biodegradable polymeric stent made from poly(L-lactide) and a low concentration of L-lactide monomer is disclosed. The concentration of L-lactide is adjusted to provide a...
8889592 Insecticidal and/or herbicidal composition having improved activity based on spiroheterocyclically substituted tetramic acid derivatives  
The present invention relates to boosting the action of crop protection compositions comprising in particular spiroheterocyclically substituted tetramic acid derivatives of the formula (I) by...
8889156 Calcium-binding agents induce hair growth and/or nail growth  
This invention provides novel methods for inducing hair growth and/or inhibiting hair loss and/or inducing nail growth in a mammal. In various embodiments the methods involve administering, e.g.,...
8889164 Antimicrobial and antiviral composition, and method of producing the same  
An antimicrobial and antiviral composition, a method of producing the same, and the like are provided, which are capable of exhibiting an excellent antimicrobial and antiviral properties over a...
8889038 Wood preservatives containing copper complexes  
This invention relates to wood preservatives containing copper complexes and calcium ions, zinc ions or calcium and zinc ions for protection of wood, cellulose, hemicellulose, lignocellulose,...
8889127 Targeted protein replacement for the treatment of lysosomal storage disorders  
The present invention relates to compositions and methods for delivering lysosomal proteins. The compositions and methods described herein permit the targeted delivery of exogenous lysosomal...
8889121 Bacterium comprising a regulated rfaH nucleic acid  
The present invention encompasses a recombinant bacterium comprising a regulated rfaH nucleic acid, as well as a vaccine comprising said recombinant bacterium. Other embodiments of the present...
8889132 Antibodies against human HIF-1α  
The invention relates to reagents and methods for detecting, diagnosing and screening for conditions associated with hydroxylated hypoxia inducible factor 1-α (HIF-1α). The invention also relates t...
8889728 Stable pharmaceutical compositions of carvedilol  
A stable solid oral pharmaceutical composition comprising carvedilol or a pharmaceutically acceptable salt thereof, which is packed using a suitable packaging material along with a desiccant. A...
8889832 Antibodies inhibiting c-Met dimerization, and uses thereof  
The present inventions relates to a process for the selection of anti c-Met antibodies capable to inhibit both ligand-dependent and ligand-independent activation of c-Met. More particularly, said...
8889725 Sugar-based bait  
An ant bait which contains an active substance having insecticidal activity and a sugar syrup is described.
8889176 Method of managing or treating pain  
A composition for the intranasal delivery of fentanyl or a pharmaceutically acceptable salt thereof to an animal includes an aqueous solution of fentanyl or a pharmaceutically acceptable salt...
8888736 High shear application in medical therapy  
In this disclosure, a method is described wherein the method comprises mixing a therapeutic gas or a therapeutic liquid or a combination thereof and a liquid carrier in a high shear device to...
8889396 Methods and compositions for improving growth of meat-type poultry  
The present invention provides methods of improving growth performance, improving the efficiency of feed utilization, increasing feed digestibility, and decreasing mortality of immature and...
8889198 Method for suppressing and relieving itching and inflammation  
The present invention provides a method for suppressing and relieving itching and inflammation, by administering to a host in need of such treatment an effective amount of the pharmaceutical...
8889133 Methods of treating diabetes with Dll4 antagonists  
The present invention provides methods of preventing, treating or ameliorating diabetes by administering to a subject in need thereof a therapeutically effective amount of Dll4 antagonists that...
8889839 Pyridine-bis (oxazoline)(“pybox”) moiety as a chelator and sensitizer for lanthanide ion (Ln (III)) Luminescence  
This invention relates to novel Ln(III) complexes of pybox, and methods of making the same. The present invention also relates to a method of use of pybox as a chelating moiety and sensitizer for...
8889122 Cellular cardiomyoplasty as supportive therapy in patients with heart disease  
The present invention provides a system for treating heart disease as a “bridge to recovery” using cellular cardiomyoplasty. The system is particularly useful in selecting and treating patients wit...
8889154 Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation  
A packaged composition of 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine dissolved in a fatty acid formulation and contained in a laminated packaging material having a contact layer that...
8889191 Sustained-release formulations of topiramate  
Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the...
8889106 Non-alcohol mouthwash composition without chemical antibacterial medicament  
A non-alcohol mouthwash composition without chemical antibacterial medicament is disclosed. The non-alcohol mouthwash composition includes from 0.03% to 1.5% of γ-polyglutamic acid (γ-PGA) and f...
8889126 Methods and compositions for treating neuropathies  
Methods of treating or preventing axonal degradation in neuropathic diseases in mammals are disclosed. The methods can comprise administering to the mammal an effective amount of an agent that acts...
8889111 Composition for the permanent shaping of human hair  
The present invention concerns a composition for the permanent shaping of human hair used both for the permanent waving of human hair with an excellent waving effect as well as for the...
8889145 Immunogenic compositions of Staphylococcus aureus antigens  
The present invention relates to immunogenic compositions, comprising polypeptides and polysaccharides from Staphylococcus aureus. The present invention also relates to immunogenic compositions,...
8889102 Neuromyelitis optica autoantibodies as a marker for neoplasia  
The present invention provides for methods and materials for diagnosing and treating neuromyelitis optica (NMO).
8889109 Pharmaceutical dosage forms comprising valganciclovir hydrochloride  
The present invention provides novel solid pharmaceutical dosage forms for oral administration, after being constituted in water. The solid dosage forms comprise a therapeutically effective amount...
8889180 Coated drug delivery formulations  
The invention relates generally to methods of making formulations for delivering biological agents to a patient. In one aspect, proliposomal drug-delivery systems for medicaments are provided. In...
8889189 Dissolution composition for examining drug solubility  
There are described solid compositions or examining drug solubility comprising bile salts and phospholipids, optionally containing buffer components suitable for preparation of intestinal media...
8889169 Drug delivery system and method of manufacturing thereof  
Irradiation of a surface of a material with a gas cluster ion beam modifies the wettability of the surface. The wettability may be increased or decreased dependent on the characteristics of the gas...
8889117 Modular nanoparticles for adaptable vaccines  
Modular nanoparticle vaccine compositions and methods of making and using the same have been developed. Modular nanoparticle vaccine compositions comprise an antigen encapsulated in a polymeric...
8889188 Luminescent conducting nano-drug crystal ultra-thin film self-assembly and uses  
This invention involves two fields of photoelectron information materials and pharmaceuticals, especially refers to the self-assembly of conducting photoluminescence nanomedicine crystals and thin...
8889619 Fusion protein of Exendin-4 and its analog, preparation method and use thereof  
Provided are a fusion protein of Exendin-4 and its analog, the preparation method and use thereof. The fusion protein is obtained by fusing of Exendin-4 or its analog to Fc region of human IgG2 via...
8889618 C-terminal fragments of glucagon-like peptide-1 (GLP-1)  
C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP 1), and methods of use thereof, e.g., for the treatment of obesity and obesity-related disorders, e.g., diabetes and the metabolic syndrome.
8889185 Modified release compositions comprising tacrolimus  
A modified release composition comprising tacrolimus which is useful for the treatment or prevention of rejection reactions by transplantation of organs or tissues.
8887715 Low dose pharmaceutical powders for inhalation  
The invention relates to a method of delivering an agent to the pulmonary system of a compromised patient, in a single breath-activated step, comprising administering a particle mass comprising an...
8889193 Sustained delivery of therapeutic agents to an eye compartment  
Compositions and methods for treating eye disorders by administering a drug delivery system into an eye compartment of the patient, wherein the drug delivery system contains a particle containing a...
8889184 Particulate form of a pharmaceutical composition which is easy to swallow  
The present invention relates to a pharmaceutical composition for direct oral administration which is very easy to swallow especially for young children, comprising at least one pharmaceutically...
8889881 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor  
Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase,...
8889138 Anti-ADDL antibodies and uses thereof  
The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can ...
8889190 Extended-release topiramate capsules  
An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein...
8889186 Modified release compositions comprising tacrolimus  
A modified release composition comprising tacrolimus releases less than 20% w/w of the active ingredient within 0.5 hours when subjected to an in vitro dissolution test using USP Paddle method and...
8889167 Plastic implant impregnated with a degradation protector  
A plastic implant device for a mammal that contains a rare earth metal compound tracer and a method for detecting degradation such as wear of the implanted device are disclosed. The tracer can also...
8889148 Flavivirus host-range mutations and uses thereof  
Methods and compositions concerning mutant flaviviruses with host-range phenotypes are provided. Nucleotide sequences that encode mutant flavivirus proteins are also provided. In certain aspects,...
8889182 Process of thermodynamical activation of water-insoluble drugs loaded into cross-linked polymers  
The present invention refers to a process to prepare a highly activated composite of one or more water-insoluble drugs, said process comprising the steps of: (a) subjecting said water-insoluble...
8889179 Membrane  
The invention relates to a membrane for supporting cells, especially retinal pigmented epithelial (RPE) cells. The membrane is useful in the treatment of conditions such as age related macular...
8888732 Intraluminal sleeve with active agents  
An intraluminal sleeve system is provided, which generally includes an intraluminal sleeve capable of dispensing an active agent to a patient, for example, a metabolic agent or satiety inducing...
8889104 Method of neutralizing an aerosol containing a compound of interest dissolved in a low pH solution  
Systems and methods for neutralizing a solution comprising a compound of interest, comprising: aerosolizing a solution, wherein the solution is a low pH solution and comprises the compound of...
8889163 Facially amphiphilic polymers as anti-infective agents  
Facially amphiphilic polyphenylene and heteroarylene polymers and articles made therform having biocidal surfaces are disclosed. The polymers can inhibit the growth of microorganisms in contact...
8888674 Methods and systems for magnetic focusing of therapeutic, diagnostic or prophylactic agents to deep targets  
Systems and methods are disclosed for trapping or focusing magnetizable particles comprising therapeutic agents at a distance using a dynamic magnetic field and feedback control, to enable the...
8889158 Intra-articularly supplementation method for treating joint diseases and injuries  
A method of producing a hydrogel for intra-articular supplement comprising the steps of: providing a solution of alginate,providing a solution with chitosan having a Mw between lower than 60...